(Reuters) – The Federal Trade Commission and 10 U.S. states on Monday sued what they called a “sham” charity that raised $18.25 million to help women […]

Clinicians are navigating how to begin treating their patients with lifileucel (Amtagvi, Iovance Biotherapeutics Inc.), a new treatment for melanoma with a hefty price tag. The […]

A new drug-device combo aimed at detecting residual cancer in real time during lumpectomy is one step closer to gaining federal approval, but some physicians aren’t […]

TOPLINE: Participation in the 340B drug discount program does not affect the use of oral specialty drugs for advanced prostate cancer, but it may boost adherence […]

TOPLINE: New data suggested that regular magnetic resonance surveillance (MRI) surveillance lowers the risk for breast cancer mortality by 80% in women with BRCA1 sequence variations, […]

Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost […]

The US Food and Drug Administration has approved nivolumab (Opdivo, Bristol-Myers Squibb) in combination with cisplatin and gemcitabine for first-line treatment of adults with unresectable or […]

The US Food and Drug Administration has granted accelerated approval to the Bruton’s kinase inhibitor zanubrutinib (Brukinsa, BeiGene USA) with obinutuzumab (Gazyva, Roche) for relapsed or […]

“Exercise is medicine” has become something of a mantra, with good reason. There’s no doubt that regular physical activity has a broad range of health benefits. […]